Early Life
Murali Krishna Prasad Divi was born in a small village in Andhra Pradesh. He came from a large family with humble beginnings, facing financial challenges. Despite these struggles, Divi was determined to pursue higher education, despite facing setbacks in his early schooling. He studied in Machilipatnam and later attended MIT, Manipal, where he started to realize the value of hard work.
Rise to Success
After briefly working in the US in the pharmaceutical industry, Divi returned to India and started Divi's Laboratories in 1990. The company initially focused on developing commercial processes for manufacturing APIs and intermediates. Divi's Labs quickly grew to become a major player in the pharmaceutical industry. Divi's Laboratories went public with its initial public offering (IPO) on February 17, 2003. Today, Divi's Laboratories is recognized as one of the top pharmaceutical companies in India.
Key Business Strategies
Divi's Laboratories focuses on manufacturing Generic APIs, Intermediates, and Nutraceutical Ingredients, and offers Custom Synthesis of APIs to Big Pharma. The company has invested in research and development with multiple R&D centers. Divi's Laboratories' revenue reached $1.1 billion in 2025, with exports accounting for nearly 90% of its revenue.
Philanthropy
Information regarding Murali Divi's specific philanthropic initiatives and amounts could not be found in the search results.